CADI-R306

CADI-R306 is a discovery-stage research and development program developed by Bio-Modeling Systems (BMSystems) targeting disorders of the Central Nervous System (CNS) and Peripheral Nervous System (PNS). The program utilizes the company's proprietary Computer Assisted Deductive Integration (CADI) platform, which generates predictive biological models to identify novel therapeutic targets and multi-target strategies for complex neurological conditions. CADI-R306 specifically focuses on the integrated mechanisms of nervous system signaling and neuro-inflammation, aiming to propose new therapeutic protocols or drug repositioning opportunities. As a discovery-phase asset, the specific molecular targets and lead candidates are currently undisclosed, reflecting the program's focus on platform-based mechanistic validation.